欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/0562/001
药品名称Protaminsulfat LEO Pharma
活性成分
    • protamine sulfate 1400.0 IU/ml
剂型solution for injection or infusion
上市许可持有人LEO Pharmaceutical Products Denmark
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Malta (MT)
    • Poland (PL)
      Protamine sulfate LEO Pharma
    • Spain (ES)
    • Slovakia (SK)
    • Netherlands (NL)
    • Czechia (CZ)
      Protaminsulfat LEO Pharma
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
    • Luxembourg (LU)
    • Iceland (IS)
    • Ireland (IE)
    • Austria (AT)
      Protaminsulfat LEO Pharma 1400 I.E. Heparin Antidot/ml - Injektions- und Infusionslösung
    • Portugal (PT)
    • Greece (GR)
    • Norway (NO)
    • Finland (FI)
    • Lithuania (LT)
      Protamine sulphate LEO Pharma 1400 antiheparino TV/ml injekcinis/infuzinis tirpalas
    • Estonia (EE)
      PROTAMINE SULPHATE LEO PHARMA
    • Slovenia (SI)
    • Italy (IT)
    • Hungary (HU)
许可日期2006/08/04
最近更新日期2024/05/13
药物ATC编码
    • V03AB14 protamine
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Bibliographic [Article 10.1(a)(ii)]
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase